REFRACTORY WHO GRADE II GLIOMA

Clinical trials for REFRACTORY WHO GRADE II GLIOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY WHO GRADE II GLIOMA trials appear

Sign up with your email to follow new studies for REFRACTORY WHO GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Engineered immune cells take aim at deadly brain cancer

Disease control Ongoing

This early-phase trial is testing a new type of personalized immunotherapy for patients with malignant brain tumors (gliomas) that have returned or stopped responding to standard treatments. Doctors collect a patient's own immune cells (T-cells), genetically modify them in a lab …

Matched conditions: REFRACTORY WHO GRADE II GLIOMA

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY WHO GRADE II GLIOMA

Get alerted when new REFRACTORY WHO GRADE II GLIOMA trials appear

Engineered immune cells take aim at deadly brain cancer